[D3-A3] Bioanalytical Strategy in Biopharmaceutical Development

3:05 PM - 3:30 PM JST(6:05 AM - 6:30 AM UTC)

[D3-A3-01] Bioanalysis in Dual-Payload ADC: Case Study of Analytical Strategy and Quantitation of total antibody and ADCs by IA-LC/MS/MS

*Yuji Fujita¹, Toshihiro Matsuda¹, Guifen Xu², Werner Rubas² (1. Astellas Pharma Inc., 2. Sutro Biopharma Inc.)

Password required to view

Log in

or